News
- Details
In 2013, Bayer (the Russian division of Bayer AG) will launch the drug production on the premises of Medsintez, an Ural plant, as Alexander Petrov, Chairman of Medsintez's Board of Directors has told.
- Details
The Medsintez plant from Novouralsk (the Sverdlovsk region, a part of the Yunona Holding), which is only four years old, was awarded the title of Laureate of the Russian Government's Prize in the field of quality.
- Details
The Medsintez plant from Novouralsk (a part of the Ural pharmaceutical holding being created by the government of the Sverdlovsk region and the Yunona holding) is to launch manufacturing of the first Russian insulin this May.
- Details
On November 26, the NovouralskMedsintez plant (the Sverdlovsk region, a part of the Yunona holding) launched a shop to produce genetic engineered insulin required by patients with diabetes mellitus. The company can enter the top 5 of the largest global manufacturers.
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130